3-alkanoyl-5-hydroxymethyl tetronic acid homologues and resistomycin: New inhibitors of HIV-1 protease. I. Fermentation, isolation and biological activity

The Journal of Antibiotics

Volumn 47, Issue 2, 1994, Pages 136-142

  Roggo, Barbara E ^a   Petersen, Frank ^a   Roesel, Johannes ^a   Delmendo, Ron ^b  

^a CIBA GEIGY LTD   (Switzerland)

^b MDS Inc   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

3 ALKANOYL 5 HYDROXYMETHYL TETRONIC ACID DERIVATIVE; PROTEINASE INHIBITOR; RESISTOMYCIN; TETRONIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ACTINOBACTERIA; ANTIBIOTIC BIOSYNTHESIS; ARTICLE; DRUG ISOLATION; DRUG SCREENING; DRUG STRUCTURE; ENZYME ASSAY; HUMAN IMMUNODEFICIENCY VIRUS 1; PRIORITY JOURNAL; PROTEINASE INHIBITION;

ACTINOMYCETACEAE; ANTIBIOTICS; BENZOPYRENES; FERMENTATION; FURANS; HIV PROTEASE INHIBITORS;

EID: 0028174509     PISSN: 00218820     EISSN: 18811469     Source Type: Journal    
DOI: 10.7164/antibiotics.47.136     Document Type: Article

References (14)

1. Kohl, N. E.; E. A. Emini, W. A. Schlief, L. J. Davis, J. C. Heimbach, R. A. F. Dixon, E. M. Scolnick & I. S. Sigal: Active human immunodeficiency virus protease is required for viral infectivity. Proc. Natl. Acad. Sci. U. S. A. 85: 4686~4690, 1988
2. Sandström, E. & B. Öberg: Antiviral therapy in human immunodeficiency virus infections. Current status (Part II). Drugs 45: 637~653, 1993
3. Tang, J.; Y. Lin, E. Co, J. A. Hartsuck & X. Lin: Understanding HIV protease: Can it be translated into effective therapy against AIDS? Scand. J. Lab. Invest. 52 (Suppl. 210): 127~135, 1992
4. Dolak, L. A.; E. P. Seest, J. I. Ciadella & M. J. Bohanon (The Upjohn Company): Compounds used for the inhibition of HIV-protease. PCT Int. Appl. 93/04055, Mar. 4, 1993
5. Brockmann, H.; E. Meyer, K. Schremp, F. Reiners & T. Reschke: Resistomycin. IV. Constitution of resistomycin. Chem. Ber. 102: 1224~1246, 1969
6. Fehrentz, J. A.; B. Chomier, E. Bignon, S. Venaud, J. C. Cherman & D. Nisato: Statine based tripeptides as potent inhibitors of HIV-1 replication. Biochem. Biophys. Res. Comm. 188: 873~878, 1992
7. Billich, S.; M-Th. Knoop, J. Hansen, P. Strop, J. Sedlacek, R. Mertz & K. Moelling: Synthetic peptides as substrates and inhibitors of Human Immunodeficiency Virus-1 Protease. J. Biol. Chem. 263: 17905~17908, 1988
8. Alteri, E.; Bold, W. Beck, E. Boss, R. Cozens, F. Cumin, A. Faessler, M. Gruetter, E. Hungerbuehler, T. Klimkait, M. Lang, J. Lazdins, B. Poncioni, J. L. Roesel, H. Rueeger, P. Schneider, M. Tintelnot-Bloomley, M. Walker & K. Woods-Cook: From renin inhibitors to CGP 53437, an orally bioavailable HIV-1 protease inhibitor. Bioorg. Med. Chem. Lett., submitted
9. Roggo, B. E.; P. Hug, S. Moss, F. Raschdorf & H. H. Peter: 3-Alkanoyl-5-hydroxymethyl tetronic acid homologues: New inhibitors of HIV-1 protease. II. Structure determination. J. Antibiotics 47: 143~147, 1994
10. Hoff, H.; H. Drautz, H. -P. Fiedler, H. Zaehner, J. E. Schultz, W. Keller-Schierlein, S. Philipps, M. Ritzau & A. Zeeck: Metabolic products of microorganisms. 261. Obscurolides, a novel class of phosphodiesterase inhibitors from streptomyces. I. Production, isolation, structural elucidation and biological activity of obscurolides A1 to A4. J. Antibiotics 45: 1096~1107, 1992
11. Rapp, C; G. Jung, C. Isselhorst-Scharr & H. Zaehner: A new member of the class of antibiotics with thiotetronic acid structure isolated from Streptomyces olivaceus Tü 3010. Liebigs Ann. Chem. 11: 1043~1047, 1988
12. Hoff, H.: Obskurolide: Neue Butyrolactone aus Streptomyceten. Ph. D. Thesis, Univ. Tübingen, 1990
13. Bradler, G. & K. Eckhardt: Characterization of a Streptomyces strain producing resistomycin. Isolation and properties of the new antibiotic. Z. Allg. Mikrobiol. 12: 535~545, 1972
14. Haupt, I.; U. Waehnert, C. Pitra, G. Loeber, G. Luck & K. Eckardt: Effects of the antibiotic resistomycin on the synthesis of macromolecules. Z. Allg. Mikrobiol. 15: 411~421, 1975